Pharma & Healthcare

Immupharma Plc

ImmuPharma PLC major interest from Alto Invest

ImmuPharma PLC (LSE:IMM) the specialist drug discovery and development company, has told DirectorsTalk that on 24 May 2016 it received notification by Alto Invest and its subsidiaries (“Alto”) confirming its holding